Noven is a fully-integrated specialty pharmaceutical company with industry-leading transdermal expertise


Women's Health

Developing and commercializing therapies for women’s menopausal health concerns has been a cornerstone of Noven’s business since it was founded in 1987. In this area, Noven developed the first FDA-approved adhesive matrix estrogen therapy patch, the first approved combination (two-drug) patch, Combipatch® (estradiol/norethindrone acetate transdermal system) and the planet’s smallest estrogen patch, Minivelle® (estradiol transdermal system). Noven also manufactures hormone therapy patches that are marketed and sold by partners around the world.

  Minivelle Logo CombiPatch Logo

More Information

Minivelle® and CombiPatch®
Patient, Physician
and Pharmacist Inquiries:

Tel: 800-455-8070